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ABSTRACT
The oral cavity possesses a diverse microflora, yet recurrent infections within healthy individuals are
rare. Wound healing within the buccal mucosa is preferential, potentially because of the presence of
oral mucosal lamina propria-progenitor cells (OMLP-PCs). In addition to their multipotency, OMLP-
PCs demonstrate potent immunosuppressive properties. The present study investigated whether
OMLP-PCspossessantibacterial properties, directly interactingwithmicroorganismsandcontributing
to the maintenance of a balanced oral microflora. Gram-positive and -negative bacteria were cocul-
tured with OMLP-PCs, buccal mucosal fibroblasts, or their respective conditioned media (CM). Bac-
terial growth was significantly inhibited when cocultured with OMLP-PCs or their CM. No
antibacterial activity was apparent within the fibroblasts. Analysis of the OMLP-PC CM indicated con-
stitutive secretion of osteoprotegerin (OPG) andhaptoglobin (Hp). Exposure of the bacteria toOPGor
Hpdemonstrated their differential antibacterial properties,with neutralization/blocking studies con-
firming that the growth of Gram-positive bacteria was partially restored by neutralizing OPG within
OMLP-PC CM; blocking Hp restored the growth of Gram-negative bacteria. The present study dem-
onstrates, for the first time, the broad-spectrum antibacterial properties of OMLP-PCs. We report
the direct and constitutive antibacterial nature of OMLP-PCs, with retention of this effect within
the CM suggesting a role for soluble factors such as OPG and Hp. Knowledge of the immunomodula-
tory and antibacterial properties of these cells could potentially be exploited in the development of
novel cell- or soluble factor-based therapeutics for the treatment of infectious diseases such as pneu-
monia or ailments such as chronic nonhealing wounds. STEMCELLS TRANSLATIONALMEDICINE 2015;
4:1283–1293
SIGNIFICANCE
Oral mucosal lamina propria-progenitor cells (OMLP-PCs) are a cell source with known immunomod-
ulatory properties. The present report demonstrates the novel finding thatOMLP-PCs possess potent
antibacterial properties, halting the growth of Gram-positive and -negative bacteria through the se-
cretion of soluble factors. OMLP-PCs constitutively secrete osteoprotegerin (OPG) and haptoglobin
(Hp) at levels high enough to exert antibacterial action. OPG, a glycoprotein not previously known to
be antibacterial, can suppress Gram-positive bacterial growth. Hp is only active against Gram-
negative microorganisms. These findings indicate that OMLP-PCs could offer great potential in the
development of novel cell- or soluble factor-based therapies for the treatment of infectious illness,
such as bacterial pneumonia, through systemic infusion and of chronic wounds through local
administration.
INTRODUCTION
Oral soft tissues are continually exposed to the
external environment and are thus a critical
entry point for potentially harmful bacteria
[1]. However, chronic infections are rare, po-
tentially because of antimicrobial factors se-
creted by resident cells within tissues such as
the salivary glands [2]. A decrease in specific
antimicrobial factors has been linked to the
onset of oral diseases such as periodontitis
and deficiencies in the human cathelicidin pro-
tein LL-37 [3].
Oral mucosal lamina propria-progenitor cells
(OMLP-PCs) are isolated from buccal mucosal
biopsies by differential adhesion to fibronectin
[4]. These cells are clonally expanded and are
CD44+CD90+CD105+CD166+ andCD342CD452.
They are of neural crest origin (Slug+, Snail+,
Sox10+, and Twist+) and aremultipotent (mesen-
chymal and neural lineages) [4]. In addition to
their plasticity, OMLP-PCs demonstrate potent
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immunosuppressive properties, suppressing lymphocyte prolif-
eration in a contact- and dose-independent manner, indicating
the importance of secreted factors inmediating their mechanism
of action [5].
The immunosuppressive properties of bone marrow-
derived mesenchymal stem cells (BMMSCs) are well docu-
mented [6]. BMMSCs require licensing to an anti-inflammatory
phenotype, termed “MSC2,” by exposure to proinflamma-
tory cytokines, such as interferon-g (IFN-g), to display these
properties [7]. IFN-g induces the expression of indoleamine
2,3-dioxygenase (IDO), the enzyme responsible for depleting
tryptophan, an essential factor in suppressing lymphocyte
proliferation [8].
Immunosuppressive factors, such as IDO, are also known to
have prominent antibacterial actions. This enzyme also inhibits
tryptophan-dependent bacteria such as group B streptococci
[9] and Escherichia coli [10, 11] by the depletion of tryptophan.
This knowledge has led to the hypothesis that stem cells can
act with dual properties, displaying both immunomodulatory
and antibacterial characteristics. However, limited studies have
been reported with respect to the potential antibacterial proper-
ties of stem/progenitor cells. BMMSCs have been demonstrated
to decrease the growth of a restricted number of bacteria in vitro
by the secretion of antibacterial factors such as LL-37 [12]. In vivo
studies have also documented the antibacterial nature of
BMMSCs for the treatment of conditions suchas sepsis. For exam-
ple, BMMSCs stimulate bacterial clearance within the blood in
both polymicrobial [13] and Gram-negative sepsis mousemodels
[14], potentially owing to an increase in the phagocytosis of
bacteria.
Haptoglobin (Hp) is a multifunctional glycoprotein with
knownantibacterial and immunomodulatory properties affecting
both the innate and the adaptive immune systems [15]. It is com-
posed of two a and two b chains, with the type of a chain (a1 or
a2) conveying the level of Hp activity. Three human forms are
known: Hp1-1, Hp2-1, and Hp2-2. Hp1-1with twoa1 chains dem-
onstrating the highest level of activity. Its ability to effectively
bind hemoglobin and thereby deplete iron from the environment
provides Hp with excellent antibacterial effects against multiple
bacterial and fungal pathogens [10].Normally associated asapos-
itive acute phase protein, produced by the liver and found in in-
creasing concentrations within the plasma as inflammation
occurs, no association with stem/progenitor cells has yet been
reported [16].
Osteoprotegerin (OPG) is a glycoprotein predominantly de-
scribed as a decoy receptor for the receptor activator of nuclear
factor kB ligand (RANKL), preventing nuclear kB activation. Ac-
tivation of this pathway is central to the regulation of a number
of key immune pathways and the process of osteoclastogenesis
[17].OPG is known tobe a componentof theBMMSCsecretome,
although it has been reported to not play a significant role in
MSC-mediated immunosuppression [18], but rather in regulat-
ing bone resorption [19]. Numerous reports have highlighted
a correlation among bone resorption, OPG, and periodontitis;
a condition associated with the bacteria Porphyromonas
gingivalis [20–22].
In thepresent report, we demonstrate, for the first time, the
broad-spectrum antibacterial properties of OMLP-PCs. These
findings suggest that this is an inherent and distinct property
of this PC population that does not extend to stromal fibro-
blasts. We demonstrate that OMLP-PC-mediated antibacterial
activity is through the constitutive secretion of soluble factors,
including Hp and OPG, confirming that the OMLP-PC secretome
is able to directly modulate bacterial growth in the absence of
immune cell involvement. To our knowledge, this is the first re-
port documenting the antibacterial properties of OPG and its
ability to inhibit Gram-positive bacterial growth through a bac-
teriostatic mechanism. Future investigations will focus on iden-
tifying the potential for OMLP-PC usage as a cell- or soluble
factor-based therapeutic in the treatment of infectious
diseases.
MATERIALS AND METHODS
Isolation and Maintenance of OMLP-PCs and Enriched
Fibroblasts in Culture
Disease-free buccal mucosa biopsies (n = 4) were obtained from
healthy donors undergoing orthognathic surgery at Cardiff and
Vale University Health Board (Cardiff, U.K.). The local research
ethical committee had previously approved the present study,
and thedonorswere informed in accordancewith theDeclaration
of Helsinki.
Single cell suspensionsof the laminapropriawereobtainedby
enzymatic digestion of the biopsy specimens, and OMLP-PCs
were isolated and characterized as previously described [4, 23].
In brief, OMLP-PCs were separated from the lamina propria cell
suspension by differential adhesion to fibronectin and expanded
inmonolayer culture. Cells remaining in suspension aftermultiple
adhesion steps on fibronectin (i.e., the OMLP-PC-depleted stro-
mal fraction) were termed “enriched fibroblasts” (EFs) and used
as a control oral fibroblast cell population throughout the present
study.
OMLP-PCs and EFs were maintained at 37°C in a 5% CO2
humidified atmosphere in Dulbecco’s modified Eagle’s medium
supplemented with 10% (vol/vol) fetal calf serum (FCS), 2 mM
L-glutamine, and antibiotics/antimycotics (100 U/ml penicillin
G, 100mg/ml streptomycin sulfate, and 0.25mg/ml amphotericin
B; Life Technologies, Paisley, U.K., http://www.thermofisher.
com). To remove cells from plastic for subsequent experimental
procedures, 0.05% (wt/vol) trypsin/0.53 mM EDTA (Life Technol-
ogies) was used, unless otherwise stated.
Maintenance of Microbiology Stocks
Enterococcus faecalis (NCTC 775), Pseudomonas aeruginosa
(ATCC 15692), and Staphylococcus pyogenes (NCTC 8198) were
maintained on tryptone soya agar (TSA; Oxoid Ltd., Basingstoke,
U.K., http://www.oxoid.com). Proteus mirabilis (NCTC 11938)
was maintained on cysteine lactose electrolyte deficient (CLED;
Oxoid Ltd.) agar to prevent swarming of the bacteria. Bacteria
were subcultured onto fresh agar plates weekly and grown over-
night at 37°C. Agar plates were then stored at 4°C.
Coculture of OMLP-PCs, EFs, OPG, and Human Hp With
Live Bacteria
OMLP-PCs and EFs (n = 4 donors) were used at 24–30 popula-
tion doublings for the following experiments. OMLP-PCswere
treated 6100 U/ml recombinant human IFN-g (Sigma-Aldrich,
Gillingham, U.K., http://www.sigmaaldrich.com) for 7 days
before coculture with bacteria to induce an anti-inflammatory
phenotype as confirmed by quantification of the IDO-inducing
metabolite L-kynurenine [5].
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OMLP-PCs with or without IFN-g and EFs were seeded into
24-well plates at a density of 1 3 105 cells per well in Roswell
Park Memorial Institute (RPMI) medium supplemented with
10% (vol/vol) FCS and 2mM L-glutamine. The cells were allowed
to adhere overnight at 37°C in 5% CO2. Subsequent to adhesion,
the culture medium was removed and exchanged for RPMI sup-
plemented with 10% (vol/vol) FCS, 20% (vol/vol) brain heart in-
fusion broth, and 2mM L-glutamine with or without inoculation
with 150 colony-forming units (CFUs) of bacteria. For the OPG
and human Hp coculture experiments, recombinant human
OPG (rhOPG; R&D Systems, Abingdon, U.K., http://www.
rndsystems.com) or Hp (Sigma-Aldrich) was added to 150 CFU
bacteria in suspension at 1–100 ng/ml or 10 pg/ml to 1 mg/ml,
respectively.
The CFUs of each bacterium were previously calculated from
10- or 20-ml (S. pyogenes only) overnight cultures derived from
single colonies. Cultures were spiral plated using a Whitley auto-
matic spiral plater (Don Whitley Scientific, Shipley, U.K., http://
www.dwscientific.co.uk) onto appropriate agar after 16 hours
(for cocultures) and 23 hours (for susceptibility testing) at 37°C
(and 5% CO2 for S. pyogenes). The bacterial colonies were subse-
quently counted in accordance with the manufacturer’s instruc-
tions, and the dilution for 150 CFUs was determined for each
culture period.
The cocultures were incubated at 37°C and 5% CO2 for the
calculated time to reach the mid-log phase for the control cul-
tures (individual mid-log time points were previously deter-
mined for each bacterium using growth curves starting from
an inoculation of 150 CFUs). Bacteria and OMLP-PC/EF-only cul-
tures served as controls. The conditioned media (CM) was re-
moved, serially diluted, and spiral plated onto TSA or CLED
agar (P.mirabilis) and incubated overnight at 37°C before count-
ing the bacterial colonies. The remaining CM was centrifuged at
500g for 5 minutes to remove any cell debris. For samples con-
taining bacteria, the CMwas further centrifuged at 14,000g for 2
minutes through a Pall NanosepMF centrifugal device, Bio-Inert
pore size of 0.2 mm (Sigma-Aldrich) to remove bacteria, and
stored at 280°C.
Susceptibility Testing of Live Bacteria With
OMLP-PC Secretome
A total of 100 CFUs of bacteria in phosphate-buffered saline was
added to 90ml of CM from the above coculture experiments. The
cocultureswere then incubated at 37°C and5%CO2 for 16 hours.
The bacterial cultures were serially diluted, spiral plated onto
TSA or CLED (P. mirabilis) agar, and incubated overnight at
37°C before the bacterial colonies were counted as described
above. The experiments were repeated with the addition of
0.6 mg/ml of human osteoprotegerin/TNFRSF11B neutralizing
antibody (R&D Systems) or 24 mg/ml of the polyclonal rabbit
anti-human Hp antibody (Dako, Ely, U.K., http://www.dako.
com).
Quantification of OPG Gene Expression by OMLP-PCs
Total RNA was extracted from the OMLP-PCs after coculture
with bacteria using the Illustra RNAspin Mini RNA isolation kit
(GE Healthcare Life Sciences, Little Chalfont, U.K., http://
www.gelifesciences.com) and stored at 280°C before use.
cDNA was synthesized from 0.5 mg of total RNA using random
hexamer primers and Moloney murine leukemia virus reverse
transcriptase in accordancewith themanufacturer’s instructions
(Promega, Southampton, U.K., http://www.promega.com). The
genomic level of OPG (forward: 59-GAAGGGCGCTACCTTGAGAT-
39 and reverse: 59-GCAAATGTATTTCGCTCTGG-39) and b-actin
(forward: 59-AGCTACGAGCTGCCTGAC-39 and reverse: 59-AAGG-
TAGTTTCGTGGATGC-39) within OMLP-PCs was determined by
quantitative reverse transcription-polymerase chain reaction
(qRT-PCR) using Fast SYBR Green Master Mix (Life Technologies)
according to the manufacturer’s instructions.
Quantification of OPG Level in OMLP-PC Secretome
The protein levels of secreted OPG were determined in CM
samples from the coculture experiments using the human
osteoprotegerin/TNFRSF11B DuoSet enzyme-linked immunosor-
bent assay (ELISA) (R&D Systems). The concentration of OPG in
the samples was assessed using a standard curve of rhOPG from
0 to 4000 pg/ml.
Detection of Hp in OMLP-PC Secretome
CM derived from OMLP-PCs cultured with and without 100 U/ml
IFN-g for 7 days was combined with Laemmli buffer (62 mM Tris-
HCL [pH 6.8], 10% [vol/vol] glycerol, 5% sodium dodecyl sulfate,
0.005% bromophenol blue, and 5% b-mercaptoethanol) and re-
duced by heating to 100°C for 2 minutes. The total protein con-
centration was determined using the bicinchoninic acid protein
assay (ThermoFisher) to ensure equal loading.
Samples (35mg) of total protein were separated on NuPAGE
Novex 4%–12% Bis-Tris gels (Life Technologies). A positive con-
trol of 1 mg human Hp was added to one well (Sigma-Aldrich).
The proteins were transferred to nitrocellulose membrane
(HybondECL; GE Healthcare Life Sciences) overnight at 4°C, be-
fore rinsing the membrane in deionized water. The membrane
was placed in 5% (wt/vol) nonfat milk for 1 hour at room tem-
perature with agitation before probing with polyclonal rabbit
anti-human Hp (1.2 mg/ml; Dako) diluted in 2% (wt/vol) nonfat
milk in phosphate-buffered saline (PBS) with 0.1% Tween20
(PBS-T) for 1 hour at room temperaturewith agitation. Themem-
branewaswashed inPBS-Tbeforebeing incubatedwithhorseradish
peroxidase-conjugated polyclonal swine anti-rabbit immunoglobu-
lins (0.1mg/ml; Dako) in 2% (wt/vol) nonfatmilk diluted in PBS-T for
1 hour at room temperature. The membrane was washed in PBS-T
before development using ECL Prime and exposure to Hyperfilm
(GE Healthcare Life Sciences).
AssessingEffectofOMLP-PCSecretome,OPG, andHpon
Bacterial Viability
Bacteria were assessed for viability after exposure to OMLP-PC
CM, rhOPG, and Hp, as detailed above. Bacteria were stained
using the LIVE/DEAD BacLight Bacterial Viability Kit (Life Tech-
nologies) as per the manufacturer’s instructions. Bacteria were
stained for 15 minutes before mounting onto poly-L-lysine
microscope slides under a coverslip, using the BacLight mount-
ingoil provided. Thebacteriawerevisualizedusinga fluorescent
microscope at 3100 objective under oil immersion (Olympus,
Southend-on-Sea, U.K., http://www.olympus-lifescience.com).
Live (green) and dead (red) bacterial cells were subsequently
counted using Image Pro-Plus software, version 6.0 (Media
Cybernectics, Bethesda, MD, http://www.mediacy.com). Individ-
ual bacteria in a minimum of four fields of view were counted
per condition.
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Statistical Analysis
All statistical analyses were performed using SPSS statistics, ver-
sion 20 (IBM Corp., Armonk, NY, http://www-01.ibm.com/
software/analytics/spss/). Statistical analysis to compare mean
values was performed using one-way analysis of variance with
post hoc Tukey test (equal variances assumed) or a Games-
Howell test (unequal variances determined). Variance analysis
was performed using Levene’s test. Significance was assumed
at p # .05.
RESULTS
OMLP-PCs Significantly Reduce Growth of Both
Gram-Positive and Gram-Negative Bacteria
OMLP-PCs were cultured with Gram-positive (E. faecalis and
S. pyogenes) and Gram-negative (P. aeruginosa and P. mirabilis)
bacteria to the calculated mid-log time point. The growth of
each bacterium, both Gram-positive (p , .001; Fig. 1A, 1B)
and Gram-negative (p, .001; Fig. 1C, 1D), was significantly re-
duced when cocultured with OMLP-PCs. No further inhibitory
effect was evident with previous IFN-g licensing of the PCs
(confirmation of IDO activity on IFN-g licensing shown in
supplemental online Fig. 1). Coculturing of the PC-depleted
EFs with bacteria had no significant effect on the growth of
any bacterium (Fig. 1A–1D).
OMLP-PC Secretome Constitutively Reduces Growth of
Gram-Positive and Gram-Negative Bacteria
CM from OMLP-PCs significantly reduced the growth of each
bacterium (p , .001; Fig. 2A–2D). No further inhibitory effect
was demonstrated with CM derived from OMLP-PCs previously
licensed with IFN-g or primed by pre-exposure to the bacte-
rium, with the exception of S. pyogenes. CM derived from
OMLP-PCs previously exposed to S. pyogenes further sup-
pressed the growth of this bacterium compared with CM de-
rived from unprimed OMLP-PCs (p , .001; Fig. 2B). CM from
EFs with or without previous exposure to each bacterium had
no significant effect on the growth of any of the bacteria (Fig.
2A–2D).
OPG Is Constitutively Expressed and Secreted by OMLP-
PCs
mRNA expression levels of OPG from OMLP-PCs were examined
using qRT-PCR, and the secreted levelswithin CMweremeasured
using ELISA. OPG was constitutively expressed (Fig. 3A–3D) and
secreted (average secretion of 13 ng/ml in resting OMLP-PCs;
Figure 1. OMLP-PCs demonstrate broad-spectrum antibacterial
effects in coculture with bacteria. OMLP-PCs significantly reduced
the growth of Gram-positive E. faecalis (A) and S. pyogenes (B) and
Gram-negative P. aeruginosa (C) and P.mirabilis (D) bacteria. This ef-
fect was observed irrespective of OMLP-PCs prestimulation with
IFN-g or not. EFs had no effect on bacterial growth. Data are ex-
pressed as the percentage of growth6 SEM, with bacteria-only cul-
tures set to 100%. ppp, p # .001. Abbreviations: EFs, enriched
fibroblasts; IFN-g, interferon-g; OMLP-PCs, oral mucosal lamina
propria-progenitor cells.
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Fig. 3E–3H) by OMLP-PCs, with IFN-g and/or bacterial exposure
having no further effect on these levels.
OPG Exerts Antibacterial Activity Against Gram-
Positive Bacteria
Bacteria were incubated with rhOPG at concentrations relevant
to those secreted by OMLP-PCs to examine whether OPG pos-
sesses antibacterial properties. OPG significantly decreased
the growth of Gram-positive bacteria (E. faecalis significant at
5 ng/ml, p # .01; Fig. 4A; and S. pyogenes significant at
5 ng/ml, p # .001; Fig. 4B). However, OPG demonstrated no sig-
nificant effect on the growth of either Gram-negative bacteria
(Fig. 4C, 4D).
Neutralizing OPG Partially Inhibits Antibacterial
Properties of OMLP-PCs Against Gram-Positive Bacteria
CM derived from OMLP-PCs (with or without previous bacterial
exposure) was incubated with live, Gram-positive bacteria in
the presence or absence of an OPG-neutralizing antibody. Neu-
tralization of the OMLP-PC (with or without bacterial exposure)
secreted OPG significantly increased the growth of E. faecalis
(OMLP-PC CM, p # .01, and bacterially exposed OMLP-PC CM,
p # .05; Fig. 4E) and S. pyogenes (OMLP-PC CM, p # .001,
and bacterially exposed OMLP-PC CM, p # .001; Fig. 4F) com-
pared with CM that had not been neutralized. However, neither
the growth of E. faecalis nor the growth of S. pyogenes was fully
restored to control levels by neutralization of OPG (p # .01, Fig.
4E; and p # .001, Fig. 4F, respectively).
Hp Is Constitutively Secreted by OMLP-PCs
Hp secretion fromOMLP-PCs was detected in the CMbyWestern
blot, with all three chain variants detected, suggesting the consti-
tutive secretionof thehigher activity forms,Hp1-1andHp2-1 (Fig.
5A). Hp was secreted from OMLP-PCs, irrespective of IFN-g stim-
ulation of the cells.
Hp Exerts Antibacterial Activity Against Gram-
Negative Bacteria
Bacteria were incubated with Hp to examine its antibacterial
properties. Hp significantly decreased the growth of both
Gram-negative bacteria (P. aeruginosa was significant at
50 pg/ml, p # .001 [Fig. 5B] and P. mirabilis was significant at
50 pg/ml, p # .001 [Fig. 5C]). However, Hp demonstrated no sig-
nificant effect on the growth of either Gram-positive bacterium
(Fig. 5D, 5E).
Figure 2. OMLP-PCs exert antibacterial effects through the secre-
tion of soluble factors. Conditioned media (CM) derived from
OMLP-PCs significantly reduced the growth of Gram-positive
E. faecalis(A) and S. pyogenes (B) and Gram-negative P. aeruginosa
(C) and P. mirabilis (D) bacteria. CM from EFs had no significant effect
onbacterial growth.Data areexpressed as thepercentageof growth6
SEM, with bacteria-only cultures set to 100%. ppp, p # .001. Abbrevi-
ations: EFs, enriched fibroblasts; IFN-g, interferon-g; OMLP-PCs, oral
mucosal lamina propria-progenitor cells.
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Figure 3. OMLP-PCs constitutively express and secrete OPG. OPG expression and secretion was unchanged by IFN-g priming of OMLP-PCs
and/or exposure to Gram-positive E. faecalis (A, E) and S. pyogenes (B, F) or Gram-negative P. aeruginosa (C, G) and P. mirabilis (D, H) bacteria.
Genomic expression data are presented as the fold change from resting OMLP-PCs6 SEM and OPG secretion data as ng/ml6 SEM. Abbrevia-
tions: EFs, enriched fibroblasts; IFN-g, interferon-g; OMLP-PCs, oral mucosal lamina propria-progenitor cells; OPG, osteoprotegerin.
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Blocking Hp Inhibits Antibacterial Properties of OMLP-
PCs Against Gram-Negative Bacteria
CM derived from OMLP-PCs (with or without previous bacterial
exposure) was incubated with live, Gram-negative bacteria in
the presence or absence of an anti-human Hp antibody. By block-
ing the secretedHp in theCMsamples ofOMLP-PCs (with orwith-
outbacterial exposure), thegrowthofP. aeruginosa (p # .001 for
both, with or without bacterial exposure; Fig. 5F) and P. mirabilis
(p # .01 forboth,withorwithoutbacterial exposure; Fig. 5G)was
significantly increased compared with samples in which Hp had
not been blocked. The growth of P. aeruginosa and P. mirabilis
was fully restored to control levels by blocking Hp.
OMLP-PC-Mediated Antibacterial Action
Is Bacteriostatic
Bacterial cultures were incubatedwith CMderived fromOMLP-
PCs, rhOPG (Gram-positive bacteria), or Hp (Gram-negative
bacteria), as previously stated. Subsequent to incubation, the
bacterial cultures were stained using the LIVE/DEAD BacLight
staining kit. Bacterial viability was not compromised when bac-
teria were incubated with CM with or without bacterial expo-
sure, rhOPG, or Hp (Fig. 6A–6D).
DISCUSSION
We have previously reported the potent immunomodulatory po-
tential of OMLP-PCs and their mode of action through the release
of soluble factors [5]. In addition to their immunosuppressive
properties, BMMSCs have recently been reported to display an-
tibacterial properties [12, 24], leading to the hypothesis that im-
munomodulatory OMLP-PCs might also exhibit equivalent or
potentially enhanced antibacterial properties because of their
anatomical site of origin. The present study has demonstrated a re-
producible direct antibacterial action by OMLP-PCs against both
Gram-positive and Gram-negative bacteria in a bacteriostatic
manner through the constitutive release of the differentially act-
ing soluble factors, OPG and Hp.
Figure 4. OPG demonstrated antibacterial properties against Gram-positive bacteria. OPG reduced the growth of Gram-positive bacteria
E. faecalis (A) and S. pyogenes (B) only (no effect on Gram-negative bacteria [C, D]). Blocking OPG within the conditioned media of OMLP-
PCs significantly restored thegrowthofGram-positive E. faecalis (E)andS. pyogenes (F)bacteria.Dataareexpressedas thepercentageofgrowth
6 SEM, with bacteria-only cultures set to 100%. p, p # .05; pp, p # .01; ppp, p # .001. Abbreviations: EFs, enriched fibroblasts; IFN-g,
interferon-g; OMLP-PCs, oral mucosal lamina propria-progenitor cells; OPG, osteoprotegerin.
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To date, limited evidence of stem cell-mediated antibacte-
rial action has been documented. Both IDO and LL-37 have been
implicated in the BMMSC mechanism of action [12, 24]. Within
the present study, we found evidence for the importance of
soluble factors in OMLP-PC-mediated antibacterial activity.
However, in contrast to the BMMSC reports, no expression of
LL-37 was seen within the OMLP-PCs (data not shown), and
IDO, as we have previously reported, is only inducible by
Figure 5. Haptoglobin is constitutively secreted byOMLP-PCs and demonstrates antibacterial properties against Gram-negative bacteria. (A):Hp
was constitutively detected in the conditionedmedia (CM)ofOMLP-PCs (n=3donors; lanes2, 4, and6, irrespectiveof IFN-g stimulationof the cells
[lanes 1, 3, 5]). Lane 7 indicates theHp-positive control. Hp reduced the growth of P. aeruginosa (B) andP.mirabilis (C) bacteria only (no effectwas
seen on Gram-positive bacteria [D, E]). Blocking Hp in the CM restored the growth of the Gram-negative P. aeruginosa (F) and P. mirabilis (G)
bacteria. Data are expressed as the percentage of growth6 SEM, with bacteria-only cultures set to 100%. p, p # .05; pp, p # .01; ppp, p # .001.
Abbreviations: EFs, enriched fibroblasts; Hp, haptoglobin; IFN-g, interferon-g; OMLP-PCs, oral mucosal lamina propria-progenitor cells.
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inflammatory stimuli and not constitutively expressed, as per
the antibacterial effect shown [5].
Similar antibacterial effects ofMSCs have been noted inmu-
rine models, with an increase in bacterial clearance on MSC
treatment of sepsis [25] and E. coli-induced pneumonia [26],
with lipocalin 2 thought to play a role in the latter. Our data have
demonstrated that OMLP-PCs are antibacterial via the release
of soluble factors. Additionally, we have shown that CM from
OMLP-PCs is antibacterial through a bacteriostatic mechanism,
ruling out soluble factors, which act in a bactericidal manner,
such as the family of defensins and LL-37 [27]. The constitutive
antibacterial nature of OMLP-PCs also differs from the reported
mechanism seen in BMMSCs, for which exposure to bacteria is
necessary for the cells to exert their effect by secreting soluble
factors [12]. These differential modes of action among sources
of stem cells is to be expected, and we hypothesize that in vivo
priming and the niche environment from which the cells are
derived will have a significant effect on their antibacterial
properties.
OPG is vital in bone remodeling, regulating the process by acting
as a decoy receptor for RANKL and influencing osteoclastogenesis
[28]. The major bacterium involved in periodontal disease,
P. gingivalis [29], is known to be capable of inducing OPG in human
cells. The inductionofOPGbyP. gingivalishasbeendemonstrated in
both endothelial cells [30] and gingival fibroblasts fromboth healthy
and periodontitis patients, with the varying levels potentially corre-
lating with disease status [31]. Patients with periodontitis display
lower levels of OPG within the gingival crevicular fluid [20, 21] and
gingival tissue [22] compared with healthy controls. However, each
published study todatehas comparedOPGtoRANKLwithin the con-
text of bone remodeling and osteoclastogenesis. The clinical impor-
tance of OPG alone regarding bacterial infection during periodontal
disease has not yet been explored.
We have demonstrated, for the first time, the novel anti-
bacterial properties of OPG, which exerts a direct antibacterial
action specifically against Gram-positive bacteria, through
a bacteriostatic mechanism. OPG is constitutively secreted
by OMLP-PCs at concentrations high enough to exert antibac-
terial effects. Furthermore, neutralization of OPG within the
CM significantly restored the growth of the Gram-positive
bacteria tested. However, because complete restoration in
the growth of either bacterium to control levels was not
Figure 6. OMLP-PCs exert their antimicrobial actions via bacteriostatic mechanisms. LIVE/DEAD staining of E. faecalis (A), S. pyogenes (B),
P. aeruginosa (C), and P. mirabilis (D) cultures after incubation with OMLP-PC conditioned media with or without bacterial exposure, recombi-
nant human OPG and haptoglobin. No bactericidal effect was seen with any of the test conditions. Data are expressed as the percentage of
live/dead cells 6 SEM. Black bars indicate the percentage of live cells; and checkered bars, the percentage of dead cells. Abbreviations:
EFs, enriched fibroblasts; IFN-g, interferon-g; OMLP-PCs, oral mucosal lamina propria-progenitor cells; OPG, osteoprotegerin.
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observed, we hypothesize that OPG is not the only factor in-
volved in this antibacterial mechanism against S. pyogenes
and E. faecalis.
In contrast to the other Gram-positive bacteria used in
the present study, the antibacterial effect of the CM was
greater against S. pyogenes when previous exposure of the
OMLP-PCs to the bacteria had occurred. We hypothesize that
thismight be a consequence of in vivo priming. OMLP-PCswill
have been exposed to streptococcal species in vivo, because
these are one of the predominate bacterial genera within the
oral cavity [32]. This could explain the heightened response
of the primed CM to S. pyogenes, because the cells might
have been sensitized to recognize this genus. Further inves-
tigations will determine whether the CM acts in a similar
manner to other bacteria commonly found within the oral
cavity.
Hp has long been known to display antibacterial proper-
ties against the Gram-negative bacterium E. coli [11]. Hp’s
mechanism of action is simple, sequestering iron and, there-
fore, reducing the iron available for bacteria [10]. Impor-
tantly, iron is crucial for bacterial growth, with a deficiency
causing bacterial growth inhibition [33]. Although iron is es-
sential for most bacteria, the levels required and uptake
mechanisms vary considerably between microorganisms.
Generally, Gram-negative bacteria recognize iron sources
via an outer membrane receptor. The iron is then trans-
ported into the cell by an ATP-binding cassette transporter
within the inner membrane [34]. Because Gram-positive bac-
teria lack an outer membrane, iron uptakemechanisms differ
from that of the Gram-negative bacteria. The differences in
iron uptake mechanisms are the likely reason Hp only demon-
stratedantibacterial propertiesagainst theGram-negativebacteria
examined. The studies confirmed the efficacy of Hp’s antibac-
terial properties, with bacteriostatic effects evident down to
levels as low as 50 pg/ml. Western blot analysis identified mul-
tiple isoforms of Hp constitutively expressed within the secre-
tome of the OMLP-PCs, with the presence of the a1 chain
suggesting the production of the higher affinity Hp1-1
and/or Hp2-1 isoforms. Blocking of this protein was sufficient to
completely restore bacterial growth, suggesting this is the ma-
jor mechanism of OMLP-PC antibacterial action against Gram-
negative bacteria.
Wound healing within the oral mucosa is well documented
to be preferential, characterized by rapid re-epithelialization,
remodelingof theextracellularmatrix, and rapid transition through
the inflammatory phase [23, 35–38]. Our previous work suggested
a potential role for immunomodulatory OMLP-PCs resident within
the lamina propria in orchestrating this healing response [4, 5]. The
finding that this cell source possesses additional innate antibacte-
rialpropertiessupportsthehypothesis thatOMLP-PCsoffer anovel
cell source for the development of cell- or soluble factor-basedlocal
treatment of chronic nonhealing wounds or systemic infusions for in-
fectious disorders such as bacterial pneumonia.
Additionalstudiesarerequiredtoexaminefurthertheantibacterial
factors secreted by the OMLP-PCs, particularly against Gram-positive
bacteria as the presence of OPG did not fully explain the antibacterial
properties of the cells. Future work will concentrate on investigating
the potential factors involved in these antibacterial mechanisms and
how these findings can be exploited for clinical translation.
CONCLUSION
Within the present study, we have demonstrated, for the
first time, the broad spectrum antibacterial properties of
OMLP-PCs. These PCs constitutively secrete antimicrobial soluble
factors with bacteriostatic activity against both Gram-positive
and Gram-negative bacteria. Analysis of the OMLP-PC secretome
confirmed a role forOPG in the suppression ofGram-positive bac-
terial growth and for Hp in inhibiting Gram-negative bacteria. The
findingswehave reported illustrate thepotential forOMLP-PCs in
the development of novel antibacterial cell- or soluble factor-
based therapies for conditions such aspneumonia or chronic non-
healing wounds.
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